Peer-reviewed veterinary case report
Diagnosing rare malignant eye membrane tumors in dogs
By Bundgaard Kjellingbro, Kristine et al.·Published in Acta veterinaria Scandinavica·2024·Anicura Veterinä·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Challenges in diagnosing canine spindle cell tumours using immunohistochemistry, illustrated by three nonpigmented malignant cases from the nictitating membrane.
- Species:
- dog
Plain-English summary
Three female dogs, an 8-year-old Dachshund, a 12-year-old Akita, and a 14-year-old Shetland Sheepdog, were diagnosed with rare malignant tumors on their right nictitating membranes (the third eyelid). The tumors appeared as firm, swollen masses, with some being nonpigmented and one partially pigmented and ulcerated. After testing, one dog was found to have hemangiosarcoma, while the other two had amelanotic melanomas. Despite attempts to surgically remove the tumors, all three dogs experienced regrowth, requiring multiple surgeries over time. Complete removal of the tumors is recommended for the best outcome.
People also search for: dog eye tumor treatment · Dachshund nictitating membrane cancer · Akita tumor surgery recovery
Abstract
BACKGROUND: Nonpigmented malignant spindle cell tumours of the membrana nictitans are rare in dogs. In twenty-three years only three cases have been diagnosed in Scandinavia. This study describes the three cases of malignant tumours of the membrana nictitans recorded by the Eye Pathology Section, University of Copenhagen, Denmark, with reference to the clinical appearance and work-up, the treatment and prognosis, and the histopathological description including immunohistochemistry. The three cases are compared to previous publications on canine tumours of the nictitating membrane. We emphasize the importance of using protocols that are adapted to the specific species such as dogs. Opposite the human tissue responses, we even need more than one marker when diagnosing melanomas in dogs. RESULTS: The dogs presented were an 8-year-old Dachshund, a 12-year-old Akita and a 14-year-old Shetland Sheepdog. All three dogs were entire females. All three nictitating membrane tumours developed on the right nictitating membrane as firm or multilobulated hyperaemic masses. Two of the tumours were macroscopically nonpigmented, the third being partly pigmented on the surface and ulcerated. According to the histopathology and for two of the cases immunohistochemistry with dog-adapted protocols the diagnoses included one hemangiosarcoma and two amelanotic melanomas. Tumour regrowth developed in all three cases and repeated resections were completed 1, 2 and 3 times, respectively, with recurrence experienced within 1.5 months - 3 years. CONCLUSIONS: Nonpigmented malignant spindle cell tumours of the canine membrana nictitans are rare. Treatment of choice should be complete excision with a minimal histologic tumour-free distance and in case of a recurrence a full resection of the nictitating membrane. We strongly recommend a dog-adapted protocol for immunohistochemistry.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/38396026/